PDR : physicians' desk reference

著者

• Huff, Barbara B.
• Folsom, Paul J.
• Murray, Lori

書誌事項

PDR : physicians' desk reference

J. Paul Folsom, general manager

Medical Economics, c1953-2017

• 1953 (7th ed.)
• 1954 (8th ed.)
• 1955 (9th ed.)
• 1957 (11th ed.)
• 1958 (12th ed.)
• 1959 (13th ed.)
• 1960 (14th ed.)
• 1961 (15th ed.)
• 1965 (19th ed.)
• 1966 (21st ed)
• 1968 (22nd ed.)
• 1969 (23rd ed)
• 1970 (24th ed.)
• 1971 (25th ed.)
• 1972 (26th ed.)
• 1973 (27th ed.)
• 1974 (28th ed.)
• 1975 (29th ed.)
• 1976 (30th ed.)
• 1977 (31st ed.)
• 1978 (32nd ed.)
• 1979 (33rd ed.)
• 1980 (34th ed.)
• 1981 (35th ed.)
• 1982 (36th ed.)
• 1983 (37th ed.)
• 1984 (38th ed.)
• 1985 (39th ed.)
• 1986 (40th ed.)
• 1987 (41st ed.)
• 1988 (42nd ed.)
• 1989 (43rd ed.)
• 1990 (44th ed.)
• 1991 (45th ed.)
• 1992 (46th ed.)
• 1993 (47th ed.)
• 1994 (48th ed.)
• 1995 (49th ed.)
• 1996 (50th ed.)
• 1997 (51st ed.)
• 1997 (51st ed.), suppl. A
• 1998 (52nd ed.)
• 1999 (53rd ed.)
• 2000 (54th ed.)
• 2001 (55th ed.)
• 2000 (54th ed.), suppl. A
• 2000 (54th ed.), suppl. B
• 2002 (56th ed.)
• 2002 (56th ed.), suppl. A
• 2003 (57th ed.)
• 2003 (57th ed.), suppl. A
• 2003 (57th ed.), suppl. B
• 2004 (58th ed.), suppl. A
• 2004 (58th ed.), suppl. B
• 2004 (58th ed.)
• 2005 (59th ed.)
• 2006 (60th ed.)
• 2007 (61st ed.)
• 2008 (62nd ed.)
• 2009 (63rd ed.)
• 2010 (64th ed.)
• 2011 (65th ed.)
• 2012 (66th ed.)
• 2013 (67th ed.)
• 2014 (68th ed.)
• 2015 (69th ed.)
• 2016 (70th ed.)
• 2017 (71th ed.)

タイトル別名

Physicians' desk reference to pharmaceutical specialties and biologicals

注記

1992 (46th ed.)- : published by: Montvale, N.J.: Medical Economics Data

1974 (28th ed.)- : Barabara B. Huff managing editor

Title on t.p. of 11th ed.:Physicians' desk reference to pharmaceutical specialties and biologicals; its spine title: Physicians' desk reference

2002 (56th ed.) : senior associate editor, Lori Murray

2002 (56th ed.), suppl. A: published by: Montvale, N.J. : Thomson PDR

2003 (57th ed.)- published by: Montvale, N.J. : Thomson PDR

2010 (64th ed.)- published by: Montvale, N.J. : PDR Network

2015 (69th ed.)- published by: Montvale, N.J. : PDR Prescribing Information

2018 (72th ed.)- online only: https://www.pdr.net/

内容説明・目次

巻冊次

1990 (44th ed.) ISBN 9780874897098

内容説明

With more than 1,600 color grids, this year's edition of the 40-year bestseller is comprised of 2,000 pages of detailed information on nearly 3,000 drugs. Product illustration drawings have been added as a new feature.

巻冊次

1996 (50th ed.) ISBN 9781563631528

内容説明

This is a single-volume reference comprised of FDA-approved prescription drug information. With the assurance of getting officially recognized data and the most up-to-date facts, readers can find comprehensive information on drugs, indications and adverse reactions. The book provides instant visual reference for ready identification of almost 1800 of the most widely prescribed drugs, cross-referenced by page number to the prescribing information. An easy-to-follow brand and generic name index delineates between brand and generic names for faster product searches. Manufacturer and therapeutic/pharmacologic category indices provide alternative look-up options to ensure that readers can find the information they need quickly. Other features include: a key to controlled substances and a guide to management of drug overdose; a telephone listing of certified poison control centres; a full section devoted to diagnostic product information; and a complete list of discontinued drugs.

巻冊次

1997 (51st ed.) ISBN 9781563632013

内容説明

This reference gives FDA-approved information on almost 4000 prescription drugs and important data on more than 250 drug manufacturers. It includes new drugs, including: redux, the first drug in 20 years for the management of weight-loss; arimedex for breast cancer; rilutek, the first treatment for Lou Gehrig's disease'; and the new HIV protease inhibitors, crixivan, invirase and norvir. Many familiar drugs on the market today have had their prescribing information amended with new warnings, adverse reactions and indications, as well as new uses. Also provided is: a key to controlled substances and a guide to management of drug overdeose; a telephone listing of certified poison-control centres; a full section devoted to diagnostic product information; and a complete list of discontinued drugs.

巻冊次

1998 (52nd ed.) ISBN 9781563632518

内容説明

New medicines, new drug interaction data, the most recent side effects findings, and certain drugs now removed from the market make it critical for medical practitioners to keep up-to-date with the latest prescription drug information. Not only are today's prescription drugs vital to the patient's well-being, but their effectiveness and safety can impact the integrity and security of all healthcare professionals. Topics covered in this edition include: details of current prescription drugs; how different drugs interact; findings on side effects caused by a prescribed drug; recommended dosages; clinical pharmacology; paediatric use; contraindications; and FDA use-in-pregnancy ratings. It includes information on over 4000 prescription drugs and data on more than 250 drug manufacturers. Virtually all of the newly-approved drugs are covered in this edition: Rezulin, a new treatment option for diabetes; Posicor, the first T-channel blocker for hypertension and angina; Aricept, a new drug for Alzheimer's disease; Coreg, the first new approach to heart failure treatment; Lipitor and Baycol for hypercholesterolemia; and Flomax for benign prostatic hyperplasia. Many familiar drugs already on the market have had their prescribing information substantially amended with new warnings, adverse reactions and indications, as well as new uses.

巻冊次

1999 (53rd ed.) ISBN 9781563632884

内容説明

The 1999 PDR "RM" guarantees you the security and safety of having up-to-minute official FDA-approved information on over 4,000 prescription drugs and important data on more than 250 drug manufacturers.New drugs features in this edition include Amerge and Zomig, two new oral 5-HT1 receptor agonists used to treat migraine headaches; Evista, a new treatment option for osteoporosis: Aggrastat and Integrilin, used for acute coronary syndrome; Meridia, a new obesity treatment option: Trovan, a new broad spectrum anti-bacterial agent; Rebetron. a combination therapy for chronic hepatitis C; Viagra, a new oral treatment option tot erectile dysfunction; Plavix, a new oral antiplatelet agent used to reduce the incidence of atherosclerotic events and Prandin, a new oral treatment for type 2 diabetes. Of course, updated information of vital importance for many established drugs has also been included.

巻冊次

2000 (54th ed.) ISBN 9781563633300

内容説明

Published twice yearly (June and October) the PDR(R) Supplements provide every important update between annual editions of the PDR(R) so that the physician need never again worry about missing the latest prescription drug developments. These Supplements fit neatly inside the front cover of the PDR(R) so that they are always available for ready reference.

巻冊次

2000 (54th ed.), suppl. B ISBN 9781563633447

内容説明

Published twice yearly (June and October) the PDR(R) Supplements provide every important update between annual editions of the PDR(R) so that the physician need never again worry about missing the latest prescription drug developments. These Supplements fit neatly inside the front cover of the PDR(R) so that they are always available for ready reference.

巻冊次

2001 (55th ed.) ISBN 9781563633751

内容説明

Completely revised and updated, the 2001 PDR provides FDA-approved drug information on more than 4,000 prescription drugs, over 2,100 full-color, actual-size photos of medicines for instant identification, and important data on over 250 drug manufacturers. New medicines, new drug interaction data, the most recent side effects findings, and certain drugs now removed from the market make it absolutely critical that medical and healthcare professionals keep up- to-date with the very latest prescription drug information. The 2001 PDR contains: the newest drugs-which drugs are indicated for the diagnosed condition; how different drugs interact; latest findings on side effects caused by the prescribed drug; recommended dosages; clinical pharmacology; pediatric use; contraindications; FDA use-in-pregnancy ratings; and more. Hundreds of new drugs added including: Relenza & Tamiflu, Tequin & Avelox, Synercid I.V., Celebrex, Norvir, Protonix, Elexon and Zyvox. New larger trim size allows dramatically improved readability. 3,000+ pages. Not only are today's prescription drugs vital to the patient's well-being, but their effectiveness and safety can impact the integrity and security of all involved healthcare professionals as well. New in '99 - The new 54th edition comprises 3,000 pages, is extensively illustrated in full colour, and indexes some 4,000 drugs. Important data on over 250 drug manufacturers is also presented. In today's fast-moving healthcare field, it is vital that the physician keeps abreast of: The latest drugs - which drugs are indicated for the diagnosed condition How different drugs interact Latest findings on side effects caused by the prescribed drug Recommended dosages Clinical pharmacology Paediatric use Contraindications FDA use-in-pregnancy ratings And much, much more . The 2000 PDR(R) guarantees the physician the security and safety of having up- to-the-minute official FDA-approved information on over 4,000 prescription drugs and important data on over 250 drug manufacturers. Among the new drugs featured in this edition are Xenical, the first of a new class of drugs called lipase inhibitors, indicated for obesity management including weight loss and weight maintenance when used in conjunction with a reduced-calorie diet; Avandia, a new member of a class of antidiabetic agents which acts primarily by increasing insulin sensitivity in muscle and adipose tissue; Celebrex and Vioxx, two new non-steroidal anti-inflammatory drugs; iEnbrel, a new treatment option for rheumatoid arthritis; Pletal, a phosphodieterase III inhibitor that reveribly inhibits platelet aggregation; and Agenerase, a new selective synthetic inhibitor of HIV-protease.Section 1 - Manufacturers' IndexA listing of all pharmaceutical manufacturers participating in Physicians' Desk Reference(R). All addresses, telephone numbers, and emergency contacts are given. Section 2 - Brand and Generic Name Index - This index lists every product alphabetically by both brand and generic name.Section 3 - Product Category Index - Lists products by prescribing category - allowing quick and easy identification of all agents with a given therapeutic use or mechanism of action.Section 4 - Product Identification Guide - Presents full-colour, actual size photographs of tablets and capsules, plus pictures of a variety of other dosage forms and packages. Section 5 - Product Information - The main section of the book. Includes entries for over 2,200 pharmaceuticals.

巻冊次

2002 (56th ed.) ISBN 9781563634116

内容説明

Completely revised and updated, the 2002 PDR provides FDA-approved drug information on more than 4,000 prescription drugs (brand and generic names), over 2,000 full-color, actual-size photos of medicines for instant identification, and important data on over 250 drug manufacturers. New medicines, new drug interaction data, the most recent side effects findings, and certain drugs now removed from the market make it absolutely critical that medical and healthcare professionals keep up-to-date with the very latest prescription drug information. The 2002 PDR contains: the newest drugs-which drugs are indicated for the diagnosed condition; how different drugs interact; latest findings on side effects caused by the prescribed drug; recommended dosages; clinical pharmacology; pediatric use; contraindications; FDA use-in- pregnancy ratings; and more. Among the new drugs featured in this edition are: Nexium (esomeprazole magnesium), a new proton pump inhibitor approved for the treatment of GERD and H. pylori eradication; Canasa (mesalamine), a new anti-inflammatory rectal suppository indicated for the treatment of active ulcerative proctitis; Lumigan (bimatoprost), a new ophthalmic solution approved for the reduction of elevated intraocular pressure associated with open angle glaucoma or ocular hypertension; Advair (fluticasone propionate/salmeterol xinafoate), a new combination inhalation powder approved for the maintenance treatment of asthma; Trizivir (abacavir sulfate/lamivudine/zidovudine), a new combination nucleoside analogue approved for the treatment of HIV-1 infection; Cancidas (caspofungin acetate), the first of a new class of antifungal agents called glucan synthesis inhibitors, is indicated for refractory treatment of invasive aspergillosis; Remeron SolTab (mirtazapine), a new orally disintegrating tablet for the treatment of depression; Lunelle Monthly (medroxyprogesterone acetate/estradiol cypionate), a new long acting contraceptive injection; Gleevec (imatinib mesylate), a new oral protein-tyrosine kinase inhibitor for the treatment of chronic myeloid leukemia (CML); and Valcyte (valganciclovir HCl), the new antiviral prodrug of ganciclovir, is indicated for CMV retinitis in patients with AIDS. New larger trim size allows dramatically improved readability.

目次

• Among the new drugs featured in this edition are: Nexium (esomeprazole magnesium), a new proton pump inhibitor approved for the treatment of GERD and H pylori eradication
• Canasa (mesalamine), a new anti-inflammatory rectal suppository indicated for the treatment of active ulcerative proctitis
• Lumigan (bimatoprost), a new ophthalmic solution approved for the reduction of elevated intraocular pressure associated with open angle glaucoma or ocular hypertension
• Advair (fluticasone propionate/salmeterol xinafoate), a new combination inhalation powder approved for the maintenance treatment of asthma
• Trizivir (abacavir sulfate/lamivudine/zidovudine), a new combination nucleoside analogue approved for the treatment of HIV-1 infection
• Cancidas (caspofungin acetate), the first of a new class of antifungal agents called glucan synthesis inhibitors, is indicated for refractory treatment of invasive aspergillosis
• Remeron SolTab (mirtazapine), a new orally disintegrating tablet for the treatment of depression
• Lunelle Monthly (medroxyprogesterone acetate/estradiol cypionate), a new long acting contraceptive injection
• Gleevec (imatinib mesylate), a new oral protein-tyrosine kinase inhibitor for the treatment of chronic myeloid leukaemia (CML)
• and Valcyte (valganciclovir HC1), the new antiviral prodrug of ganciclovir, is indicated for CMV retinitis in patients with AIDS.

巻冊次

2002 (56th ed.), suppl. A ISBN 9781563634130

内容説明

PDR Supplements provide every important update between annual editions of the PDR. And they fit neatly inside the front cover of the PDR where they are always available for ready reference.

巻冊次

2003 (57th ed.) ISBN 9781563634451

内容説明

You'll find the most complete data on over 4,000 drugs by brand and generic name, manufacturer and product category. Your 2003 PDR provides usage information and warnings, drug interactions, plus more than 2,000 full-size, full-color photos cross-reference to the drug.

巻冊次

2003 (57th ed.), suppl. A ISBN 9781563634475

内容説明

Medical professionals don't have to worry about missing the latest prescription drug developments throughout the year. "PDR Supplements" deliver every important update between annual editions of the PDR.

巻冊次

2004 (58th ed.), suppl. A ISBN 9781563634710

内容説明

authoritative source of FDA-approved prescription drug information;3,000 + pages containing information on more than 4,000 prescription drugs;includes clinical pharmacology, indications and usage, contraindications, drug warnings, precautions, adverse reactions, overdose, dosage and administration, and how supplied.

巻冊次

2005 (59th ed.) ISBN 9781563634970

内容説明

The new 2005 edition provides full-product labeling for more than 4,000 drugs listed by brand and generic name, usage information and warnings, drug interactions, and more than 2,000 full-size, full-color photos.

巻冊次

2006 (60th ed.) ISBN 9781563635267

内容説明

Physicians have turned to "PDR" for the latest word on prescription drugs for 60 years. Today, "PDR" is considered the standard prescription drug reference and can be found in virtually every physician's office, hospital, and pharmacy; and nine out of ten doctors consider "PDR" their most important drug reference source. This work contains 3,000+ pages containing information on more than 4,000 prescription drugs. The new format allows dramatically improved readability and easier access to the information. It is an authoritative source of FDA-approved prescription drug information; and includes clinical pharmacology, indications and usage, contraindications, drug warnings, precautions, adverse reactions, overdose, dosage and administration. It contains more than 2,000 full-size, full-colour photographs cross-referenced to the product information.

巻冊次

2007 (61st ed.) ISBN 9781563635687

内容説明

The 61st edition contains more than 3,000 pages?our most comprehensive edition ever! Our new format allows dramatically improved readability and easier access to the information you need now. You?ll find the most complete data on more than 4,000 drugs by brand and generic name (both in the same convenient index), manufacturer, and product category. Your 2007 PDR provides usage information and warnings, drug interactions, plus more than 2,000 full-size, full-color photos cross-referenced to the drug. You will also find: > Phonetic spelling for each listing > A key to controlled substances > Dosages > Clinical pharmacology > FDA use-in-pregnancy ratings > Adverse reactions > Contraindications > Pediatric use > And all other FDA-required information

巻冊次

2008 (62nd ed.) ISBN 9781563636608

内容説明

Today, "PDR" is considered the standard prescription drug reference and can be found in virtually every physician's office, hospital, and pharmacy. This title contains 3,000+ pages containing information on more than 4,000 prescription drugs. The new format allows dramatically improved readability and easier access to the information. It is the authoritative source of FDA-approved prescription drug information for over 60 years. It includes clinical pharmacology, indications and usage, contraindications, drug warnings, precautions, adverse reactions, overdose, dosage and administration. It also contains more than 2,000 full-size, full-colour photographs cross-referenced to the product information.

巻冊次

2009 (63rd ed.) ISBN 9781563637032

内容説明

The new 2009 Edition of "PDR[registered]" is now here - ready to provide the vital information you need to know about all the newly approved drugs available. "PDR[registered]" has been the authoritative source of FDA-approved information on prescription drugs for more than 62 years. No medical reference is more comprehensive, more current, more user-friendly, or more recognized and respected. The "2009 PDR[registered]" includes more than 3,000 drugs organized by brand and generic name, manufacturer and product category. It also provides usage information and warnings, drug interactions, plus more than 1,800 full-size, full-color photos, cross referenced to the drug. And this year it's even more important to receive your new "PDR[registered]", since there are so many new treatments you'll want to learn about including: Afluria, Doribax, Exforge, Ixempra, Kuvan, Renvela, Tekturna, and, Xyzal.

巻冊次

2010 (64th ed.) ISBN 9781563637483

内容説明

The 2010 PDR(r) is the 64th edition, of the Physicians' Desk Reference, providing the most accurate FDA-regulated informaiton on more than 2,400 prescription drugs. PDR contains full label information on the most commonly prescribed drugs, hundreds of full-size and full-color photographs, warning and drug interactions. This years's edition features: Comprehensive indexing (by manufacturer, brand/generic name, therapeutic category, generic/index) New drug information (approved in 2009) Color images of medications Full prescribing informaiton, including pharmacokinetics and mechanism of action, indications & contraindications, trials data, side effects, warnings, and precautions and much more...PDR is the most authoritative source of FDA-regulated information on prescription drugs available! No medical reference is more current, more user-friendly, or more recognized and respected. PDR is completely revised and updated every year for your safety and peace of mind. For absolutely accurate information that physicians have turned to for over 63 years, order your copy of the 2010 Physicians' Desk Reference today!

巻冊次

2011 (65th ed.) ISBN 9781563637803

内容説明

"Monosaccharides: Their Chemistry and Their Roles in Natural Products", Peter Collins University of London, UK Robin Ferrier Victoria University of Wellington, NZ: An in-depth text for students starting their study of carbohydrate chemistry. "Monosaccharides" relates the vast field of carbohydrate chemistry to both synthetic organic chemistry and biological processes. The structures and reactions of monosaccharides are examined in detail and their applications in synthesis and as biologically active compounds are discussed and explained at length. This textbook, written by two well-known experienced teachers and researchers in carbohydrate chemistry, provides: up-to-date coverage of this rapidly expanding and developing field; classification of monosaccharide reactions according to reaction site; treatment of monosaccharides as organic compounds with rationalized chemistry; more than 1000 references to the primary literature; and, a discussion of monosaccharides as components of biologically active compounds. "Monosaccharides" will be invaluable for students and lecturers alike in organic, bioorganic and natural products chemistry, biochemistry, glycobiology and molecular biology.

目次

Preliminary Matters--Structures, Shapes and Sources. Reactions and Products of Reactions at the Anomeric Centre. Reactions and Products of Reactions at Non-Anomeric Carbon Atoms. Reactions and Products of Reactions of the Hydroxyl Groups. The Chemical Synthesis of Oligosaccharides. Synthesis of Enantiomerically Pure Non-Carbohydrate Compounds by Use of Monosaccharides. Natural Products Related to and Containing Monosaccharides. Appendices. Indexes.

巻冊次

2012 (66th ed.) ISBN 9781563638008

内容説明

"PDR" has been the premier reference on prescription drugs for 66 years. This highly respected, instantly recognized book is found in nearly every physician's office, clinic, hospital, pharmacy, and library. Completely updated every year, "PDR" provides critical, current information on the most commonly prescribed drugs in the U.S. Every full, FDA-approved drug label in "PDR" includes: Dosages; Indications; Warnings and precautions; Side effects; Safety information such as contraindications, pregnancy ratings, and more; Interactions with other drugs, food, or alcohol; Clinical trials data; Time-sensitive email reports delivering news of important label changes, new FDA product approvals and other health-related information; and, Comprehensive indexing by a drug's brand and generic name, as well as by its manufacturer and therapeutic category, gives users multiple, easy ways to access the information they seek. "PDR" also includes a product identification guide with hundreds of full-color images of products.

巻冊次

2013 (67th ed.) ISBN 9781563638138

内容説明

Physicians' Desk Reference has been the authoritative source on prescription drugs for 67 years. Found in virtually every physician's office, pharmacy, clinic, and library, no medical reference is more current, more recognized, or more respected. Now in its 67th edition, PDR contains full, FDA-approved drug label information, including warnings and precautions, drug interactions, and hundreds of full-color pill images. Every label in PDR includes information on dosages, side effects, and safety information, such as contraindications, pregnancy ratings, and interactions with other drugs, food, and alcohol. Data on clinical trials are also included.

巻冊次

2014 (68th ed.) ISBN 9781563638251

内容説明

Physicians' Desk Reference has been the authoritative source on prescription drugs for 68 years. Found in virtually every physician's office, pharmacy, clinic, and library, no medical reference is more current, more recognized, or more respected. Now in its 68th edition, PDR contains full, FDA-approved drug label information, including warnings and precautions, drug interactions, and hundreds of full-color pill images. Every label in the PDR includes information on dosages, side effects, and safety information, such as contraindications, pregnancy ratings, and interactions with other drugs, food, and alcohol. Data on clinical trials are also included.

巻冊次

2015 (69th ed.) ISBN 9781563638305

内容説明

The "Physicians' Desk Reference" has been the premier reference on prescription drugs for 69 years. This highly respected, instantly recognized book is found in nearly every physician's office, clinic, hospital, pharmacy, and library. Completely updated every year, the "PDR" provides critical, current information on the most commonly prescribed drugs in the U.S. Every full, FDA-approved drug label in the "PDR" includes dosages, indications, warnings and precautions, side effects, safety information such as contraindications, pregnancy ratings, interactions with other drugs, food, and alcohol, clinical trials data, time-sensitive email reports delivering news of important label changes, new FDA product approvals, and other health-related information. Comprehensive indexing by a drug's brand and generic name, as well as by its manufacturer and therapeutic category, gives users multiple, easy ways to access the information they seek. The "PDR" also includes a product identification guide with hundreds of full-color images of products.

巻冊次

2016 (70th ed.) ISBN 9781563638343

内容説明

Physicians' Desk Reference has been the authoritative source on prescription drugs for 70 years. Found in virtually every physician's office, pharmacy, clinic, and library, no medical reference is more current, more recognized, or more respected. Now in its 70th edition, PDR contains full, FDA-approved drug label information, including warnings and precautions, drug interactions, and hundreds of full-color pill images. Every label in PDR includes information on dosages, side effects, and safety information, such as contraindications, pregnancy ratings, and interactions with other drugs, food, and alcohol. Data on clinical trials are also included.

巻冊次

2017 (71th ed.) ISBN 9781563638381

内容説明

The Physicians' Desk Reference has been the authoritative source on prescription drugs for 71 years. Found in virtually every physician's office, pharmacy, clinic, and library, no medical reference is more current, more recognized, or more respected. Now in its 71st edition, PDR contains full, FDA-approved drug label information, including warnings and precautions, drug interactions, and hundreds of full-color pill images. Every label in PDR includes information on dosages, side effects, and safety information, such as contraindications, pregnancy ratings, and interactions with other drugs, food, and alcohol. Data on clinical trials are also included.

「Nielsen BookData」 より

詳細情報

• NII書誌ID(NCID): BA09885002
• ISBN:
  • 0874899826
  • 0874899990
  • 0874899524
  • 0874899591
  • 0874898501
  • 0874898595
  • 0874898684
  • 0874898781
  • 0874898862
  • 0874898358
  • 0874898447
  • 0874897009
  • 0874897092
  • 0874897165
  • 1563630036
  • 156363015X
  • 1563630613
  • 1563630877
  • 1563631520
  • 1563632012
  • 1563632225
  • 1563632519
  • 1563632888
  • 1563633302
  • 1563633752
  • 1563633442
  • 1563633442
  • 1563634112
  • 1563634139
  • 1563634457
  • 1563634473
  • 1563634716
  • 156363497X
  • 1563635267
  • 1563635682
  • 1563636603
  • 9781563637032
  • 9781563637483
  • 9781563637803
  • 9781563638008
  • 9781563638138
  • 9781563638251
  • 9781563638305
  • 9781563638343
  • 9781563638381
• 出版国コード: us
• タイトル言語コード: eng
• 本文言語コード: eng
• 出版地: Oradell, N.J.
• ページ数/冊数: v.
• 大きさ: 26-32 cm
• 件名:
  • MESH : Catalogs, Drug